We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.33B
AUM Growth
+$413M
Cap. Flow
+$332M
Cap. Flow %
24.95%
Top 10 Hldgs %
26.03%
Holding
123
New
17
Increased
53
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$27.7M
2
SNDK
SANDISK CORP
SNDK
+$26.1M
3
STLD icon
Steel Dynamics
STLD
+$19.7M
4
XPO icon
XPO
XPO
+$19.4M
5
MBLY
Mobileye N.V.
MBLY
+$19.2M

Top Sells

Rank Stock Value
1
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$20.4M
2
LYB icon
LyondellBasell Industries
LYB
+$10.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.3M
4
PCYC
PHARMACYCLICS INC
PCYC
+$10.1M
5
MEOH icon
Methanex
MEOH
+$9.23M

Sector Composition

Rank Sector Weight
1 Healthcare 25.62%
2 Technology 20.76%
3 Consumer Discretionary 14.72%
4 Industrials 11.01%
5 Energy 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADVM
101
DELISTED
Adverum Biotechnologies
ADVM
$1.51M 0.11%
3,740
+500
+15% +$211K
LOXO
102
DELISTED
Loxo Oncology, Inc
LOXO
$1.43M 0.11%
+114,600
New +$1.43M
PCRX icon
103
Pacira BioSciences
PCRX
$1.06B
$1.18M 0.09%
13,300
– –
FEIC
104
DELISTED
FEI COMPANY
FEIC
$1.13M 0.09%
14,800
– –
MDSO
105
DELISTED
Medidata Solutions, Inc.
MDSO
$927K 0.07%
18,900
– –
TFX icon
106
Teleflex
TFX
$5.86B
$701K 0.05%
5,800
– –
XOMA
107
DELISTED
Xoma
XOMA
$645K 0.05%
8,860
– –
RPTP
108
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$326K 0.02%
30,000
– –
VSTM icon
109
Verastem
VSTM
$536M
$213K 0.02%
1,742
– –
CDXS icon
110
Codexis
CDXS
$159M
$46K ﹤0.01%
+10,000
New +$35.3K
LRMR icon
111
Larimar Therapeutics
LRMR
$398M
$24K ﹤0.01%
50
– –
BRKR icon
112
Bruker
BRKR
$9.79B
– –
-73,900
Closed -$1.45M
KPTI icon
113
Karyopharm Therapeutics
KPTI
$159M
– –
-2,000
Closed -$1.12M
LYB icon
114
LyondellBasell Industries
LYB
$19.5B
– –
-133,900
Closed -$10.6M
LITS
115
Lite Strategy Inc
LITS
$33.6M
– –
-1,279
Closed -$109K
MEOH icon
116
Methanex
MEOH
$4.27B
– –
-201,300
Closed -$9.23M
TLPH icon
117
Talphera
TLPH
$70.1M
– –
-6,970
Closed -$938K
WPX
118
DELISTED
WPX Energy, Inc.
WPX
– –
-150,000
Closed -$1.75M
PCYC
119
DELISTED
PHARMACYCLICS INC
PCYC
– –
-82,600
Closed -$10.1M
TRW
120
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
– –
-198,400
Closed -$20.4M
HPTX
121
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
– –
-76,300
Closed -$1.83M
SLXP
122
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-11,800
Closed -$1.36M
NPSP
123
DELISTED
NPS PHARMACEUTICALS INC
NPSP
– –
-223,900
Closed -$8.01M
1 2 3 4
5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, Eventide Asset Management held 123 positions worth $1.33B, up 45% from $916M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $332M of net new capital in Q1 2015, opening 17 new positions and adding to 53 existing holdings. Its largest new stake was Lam Research: 3,509,000 shares worth $24.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $10.3M trimmed.

  • Eventide Asset Management's largest Q1 2015 buy was Lam Research: 3,509,000 shares worth $24.6M.
  • Eventide Asset Management added most to XPO in Q1 2015, an estimated $19.4M increase.
  • Eventide Asset Management's biggest Q1 2015 reduction was Agios Pharmaceuticals, cutting an estimated $10.3M.
  • Eventide Asset Management fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q1 2015, selling an estimated $20.4M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.33B portfolio in Q1 2015.
  • Eventide Asset Management opened 17 new positions and closed 12 in Q1 2015.
  • Eventide Asset Management's portfolio value rose 45% quarter-over-quarter to $1.33B.

Based on Eventide Asset Management's 13F filing for Q1 2015, filed 14 May 2015.